open/close global search bar

30 April 2012 by Evangelos D. Michelakis

Conference talk

Group II Part VI: E. Michelakis: the RV in PAH trials

All credits to Prof. E. Michelakis FPVRI, University of Alberta, Alberta, Canada

Presentation at the 2nd PVRI/FDA Conference, Bethesda, Washington DC, April 30-May 1st 2012

 

Additional key-words:  right ventricle,PREDICT,SERAPH,sildenafil,bosentan

About the author

profile picture of Evangelos D. Michelakis

Evangelos D. Michelakis

University of Alberta

Canada

Related Content

Michiel Alexander de Raaf: Targeting the cause, affecting the course thumbnail image

Conference talk

17 October 2016

{{GlobalController.truncateTitle("Michiel Alexander de Raaf: Targeting the cause, affecting the course", 65)}}
Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension thumbnail image

Original Research

{{GlobalController.truncateTitle("Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension", 65)}}
Brad Maron - Systems biology in PAH: an integrated approach to a complex disease thumbnail image

Conference talk

14 January 2016

{{GlobalController.truncateTitle("Brad Maron - Systems biology in PAH: an integrated approach to a complex disease", 65)}}
Martin Wilkins - Targeting metabolic change thumbnail image

Conference talk

14 January 2016

{{GlobalController.truncateTitle("Martin Wilkins - Targeting metabolic change", 65)}}
Ghazwan Butrous - Pulmonary Hypertension in 2015: A year in review thumbnail image

Conference talk

04 February 2016

{{GlobalController.truncateTitle("Ghazwan Butrous - Pulmonary Hypertension in 2015: A year in review", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg